关键词：体外诊断测试；诊断；筛选；管理；人类和动物；疾病
摘 要：IVD tests help in diagnosing, screening, and managing diseases in humans and animals. The tests are usually performed in a controlled environment. IVD tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play an important role in supporting decision making in clinical conditions. Advances in IVD have led to the development of POC and self-testing, which are easy and convenient for both patients and medical professionals. IVD tests can be performed in a variety of settings including a clinical laboratory, a physician’s office, or at home.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. US Healthcare Reform

07. Reimbursement and Coverage: An

Overview

08. Market Landscape

08.1 Market Overview

08.2 Market Size and Forecast

08.2.1 Business Impact of Key Factors on Vendors

08.3 Five Forces Analysis

09. Market Segmentation by Application

10. Market Segmentation by Technique

11. Market Segmentation by Component

11.1 Consumables Market in US

11.1.1 Market Size and Forecast

11.2 Instruments Market in US

11.2.1 Market Size and Forecast

11.3 Services Market in US

11.3.1 Market Size and Forecast

12. Market Segmentation by End-users

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

20.1 Competitive Scenario

20.1.1 Key News

20.1.2 Mergers and Acquisitions

20.2 Market Share Analysis 2014

20.3 Other Prominent Vendors

21. Key Vendor Analysis

21.1 Abbott Diagnostics

21.1.1 Key Facts

21.1.2 Business Overview

21.1.3 Geographical Presence

21.1.4 SWOT Analysis

21.2 BioMeriux

21.2.1 Key Facts

21.2.2 Business Overview

21.2.3 Business Segmentation by Revenue 2013

21.2.4 Geographical Segmentation by Revenue 2013

21.2.5 Business Strategy

21.2.6 Recent Developments

21.2.7 SWOT Analysis

21.3 Danaher

21.3.1 Key Facts

21.3.2 Business Overview

21.3.3 Business Segmentation

21.3.4 Revenue by Business Segmentation

21.3.5 Revenue Comparison 2012 and 2013

21.3.6 Segmentation by Geography

21.3.7 Business Strategy

21.3.8 Key Information

21.3.9 SWOT Analysis

21.4 Roche Diagnostics

21.4.1 Key Facts

21.4.2 Business Overview

21.4.3 Business Segmentation by Revenue 2014

21.4.4 Business Segmentation by Revenue 2013 and 2014

21.4.5 Geographical Segmentation by Revenue 2014

21.4.6 Business Strategy

21.4.7 Recent Developments

21.4.8 SWOT Analysis

21.5 Siemens Healthcare Diagnostics

21.5.1 Key Facts

21.5.2 Business Overview

21.5.3 SWOT Analysis

22. Other Reports in this Series